Based on present in vitro results, we propose for the first time that 3HB regulates ERK1/2 activity via HCAR2/Ca2+/cAMP/PKA/Raf1, optimizing PPARγ function from the aspect of post-translational modification to reduce insulin resistance. The gene discussed is RAF1; the disease is Insulin resistance.